Skip to main content

Table 3 Work productivity assessment of patients at baseline

From: Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)

Work productivity assessment No. of patients Response, n (%) or mean ± SD
Employed at baseline 575 Yes: 262 (45.6)
Employed when CD symptoms began 313 Yes: 161 (51.4)
Stopped working due to CD 161 Yes: 59 (36.6)
Employment status affected by CD 262    • Different job with less responsibility or pay: 14 (5.3)
      • Same job, reduced hours or responsibility: 50 (19.1)
      • No change: 198 (75.6)
Missed work in past month due to CD 261 Yes: 74 (28.4)
Number of missed work days in past month 74 5.7 ± 11.6
Decreased productivity due to CD 261 Yes: 150 (57.5)
Estimated decrease in work productivity (%) 150 72.1 ± 20.5
Have received disability benefits due to CD 262 Yes: 12 (4.6)
Duration of disability benefits (months) 12 33.2 ± 60.8
  1. CD: cervical dystonia; SD: standard deviation.